Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 1CAPITAL AND CODEINE
02 8CLOBAZAM
03 1E.E.S.
04 1E.E.S. 400
05 2EMFLAZA
06 1ERYPED
07 1FLOLIPID
08 1FURADANTIN
09 2GRISEOFULVIN
10 1LIKMEZ
11 1NAPROSYN
12 1NAPROXEN
13 1NITROFURANTOIN
14 3NYSTATIN
15 3PHENYTOIN
16 1PRAVASTATIN SODIUM
01 19175
02 118965
03 140342
04 140521
05 250207
06 161905
07 162512
08 162876
09 165200
10 165438
11 174190
12 176939
13 186024
14 189892
15 1201355
16 1203621
17 1206679
18 1208684
19 1208685
20 1208819
21 1209715
22 1210039
23 1210546
24 1210569
25 1210746
26 1211259
27 1213110
28 1216755
01 27No
02 2Yes
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : NITROFURANTOIN
Dosage Form : SUSPENSION; ORAL
Application Number : 201355
Country : US
Patented : No
Drug : PRAVASTATIN SODIUM
Dosage Form : TABLET; ORAL
Application Number : 76939
Country : US
Patented : No
Drug : NAPROSYN
Dosage Form : SUSPENSION; ORAL
Application Number : 18965
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 208819
Country : US
Patented : No
Drug : FURADANTIN
Dosage Form : SUSPENSION; ORAL
Application Number : 9175
Country : US
Patented : No
Drug : NYSTATIN
Dosage Form : SUSPENSION; ORAL
Application Number : 203621
Country : US
Patented : No
Drug : EMFLAZA
Dosage Form : SUSPENSION; ORAL
Application Number : 208685
Country : US
Patented : No
Drug : EMFLAZA
Dosage Form : TABLET; ORAL
Application Number : 208684
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 211259
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : FLOLIPID
Dosage Form : SUSPENSION; ORAL
Application Number : 206679
Country : US
Patented : Yes
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
